Lower insulin sensitivity differentiates hirsute from non-hirsute Sicilian women with polycystic ovary syndrome

European Journal of Endocrinology

Volumn 155, Issue 6, 2006, Pages 859-865

  Amato, Marco C ^a   Galluzzo, Aldo ^a   Merlino, Simona ^a   Mattina, Antonina ^a   Richiusa, Pierina ^a   Criscimanna, Angela ^a   Giordano, Carla ^a  

^a UNIVERSITY OF PALERMO   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN; ANDROSTENEDIONE; CPEPTIDE; GLUCOSE; INSULIN; PRASTERONE SULFATE; SEX HORMONE; TESTOSTERONE; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; AREA UNDER THE CURVE; ARTICLE; BODY MASS; CONTROLLED STUDY; DIET RESTRICTION; FEMALE; GLUCOSE BLOOD LEVEL; HIRSUTISM; HOMEOSTASIS; HUMAN; INSULIN RESISTANCE; INSULIN SENSITIVITY; INSULINEMIA; ITALY; MAJOR CLINICAL STUDY; MODEL; OBESITY; ORAL GLUCOSE TOLERANCE TEST; OVARY POLYCYSTIC DISEASE; PRIORITY JOURNAL; SCORING SYSTEM;

ADOLESCENT; ADULT; ANDROSTENEDIONE; DEHYDROEPIANDROSTERONE SULFATE; DIAGNOSIS, DIFFERENTIAL; FEMALE; HIRSUTISM; HUMANS; HYPERANDROGENISM; HYPERINSULINISM; INSULIN RESISTANCE; METABOLIC SYNDROME X; OBESITY; POLYCYSTIC OVARY SYNDROME; SICILY; TESTOSTERONE;

EID: 33846007242     PISSN: 08044643     EISSN: None     Source Type: Journal    
DOI: 10.1530/eje.1.02290     Document Type: Article

References (29)

1. Knochenhauer ES, Key TJ, Kahsar-Miller M, Waggoner W, Boots LR & Azziz R. Prevalence of the polycystic ovary syndrome in unselected black and white women of the southeastern United States: a prospective study. Journal of Clinical Endocrinology and Metabolism 1998 83 3078-3082.
2. Diamanti-Kandarakis E, Kouli CR, Bergiele AT, Filandra FA, Tsianateli TC, Spina GG, Zapanti ED & Bartzis MI. A survey of the polycystic ovary syndrome in the Greek island of Lesbos: hormonal and metabolic profile. Journal of Clinical Endocrinology and Metabolism 1999 84 4006-4011.
3. Azziz R, Woods KS, Reyna R, Key TJ, Knochenhauer ES & Yildiz BO. The prevalence and features of polycystic ovary syndrome in an unselected population. Journal of Clinical Endocrinology and Metabolism 2004 89 2745-2749.
4. Livingstone C & Collison M. Sex steroids and insulin resistance. Clinical Science 2002 102 151-166.
5. The Rotterdam ESHRE/ASRM-sponsored PCOS consensus workshop group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Human Reproduction 2004 1 41-47.
6. Taylor AE. Polycystic ovary syndrome. Endocrinology and Metabolism Clinics of North America 1998 4 877-902.
7. Poretsky L, Cataldo NA, Rosenwaks Z & Giudice LC. The insulin-related ovarian regulatory system in health and disease. Endocrinology Review 1999 20 535-582.
8. Sukalich S & Guzick D. Cardiovascular health in women with polycystic ovary syndrome. Seminars in Reproductive Medicine 2003 21 309-315.
9. Hardiman P, Pillay OC & Atiomo W. Polycystic ovary syndrome and endometrial carcinoma. Lancet 2003 361 1810-1812.
10. Poretsky L. On the paradox of insulin-induced hyperandrogenism in insulin resistant states. Endocrinology Review 1991 12 3-13.
11. Cenk Sayin N, Gucer F, Balkanli-Kaplan P, Ali Yuce M & Yardim T. Insulin resistance and lipid profile in women with polycystic appearing ovaries: implications with regard to polycystic ovary syndrome. Gynecological Endocrinology 2003 17 387-396.
12. Dunaif A, Segal KR, Futterweit W & Dobrjansky A. Profound peripheral insulin resistance, indipendent of obesity in polycystic ovary syndrome. Diabetes 1989 38 1165-1174.
13. Van Dam EW, Roelfsema F, Veldhuis ID, Hogendoorn S, Westenberg J, Helmerhorst FM, Frolich M, Krans HM, Meinders AE & Pijl H. Retention of estradiol negative feedback relationship to LH predicts ovulation in response to caloric restriction and weight loss in obese patients with polycystic ovary syndrome. American Journal of Physiology - Endocrinology and Metabolism 2004 286 615-620.
14. Pasquali Rand Gambineri A. Insulin-sensitizing agents in polycystic ovary sindrome. European Journal of Endocrinology 2006 154 763-775.
15. Ehrmann DA. Polycistic ovary syndrome. New England Journal of Medicine 2005 352 1223-1236.
16. Zhang LH, Rodriguez H, Ohno S & Miller WL. Serine phosphorylation of human P450c17 increases 17.20 lyase activity: implications for adrenarche and the polycystic ovary syndrome. PNAS 1995 92 10619-10623.
17. Ferriman D & Gallwey JD. Clinical assessment of body hair growth in women. Journal of Clinical Endocrinology and Metabolism 1961 21 1440-1447.
18. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF & Turner RC. Homeostasis model assessment: insulin resistance and Βcell function from fasting plasma glucose and insulin in man. Diabetologia 1985 28 412-419.
19. Matsuda M & De Fronzo RA. Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. Diabetes Care 2001 24 460-464.
20. Radikova Z. Assessment of insulin sensitivity/resistance in epidemiological studies. Endocrine Regulation 2003 37 189-194.
21. The IDFconsensus worldwide definition of the metabolic syndrome [article on line]. Available from http://www.idf.org, 2005.
22. Sozen I & Arici A. Hyperinsulinism and its interaction with hyperandrogenism in polycystic ovary syndrome. Obstetrical and Gynecological Survey 2000 55 321-328.
23. Philpott MP, Sanders DA & Kealey T. Effects of insulin and insulin-like growth factors on cultured human hair follicles: IGF-I at physiologic concentrations is an important regulator of hair follicle growth in vitro. Journal of Investigative Dermatology 1994 102 857-861.
24. Itami S, Kurata S & Takayasu S. Androgen induction of follicular epithelial cell growth is mediated via insulin-like growth factor-I from dermal papilla cells. Biochemical and Biophysical Research Communications 1995 212 988-994.
25. Ünlühizarci K, Karababa Y, Bayram F & Kelestimur F. The investigation of insulin resistance in patients with Idiopathic Hirsutism. Journal of Clinical Endocrinology and Metabolism 2004 89 2741-2744.
26. Falsetti L, Gambera A, Andrico S & Sartori E. Acne and hirsutism in polycystic ovary syndrome: clinical, endocrine-metabolic and ultrasonographic differences. Gynecological Endocrinology 2002 16 275-284.
27. Norman RJ & McVeigh E. Polycystic ovary syndrome and implications for the menopause. Climacteric 1999 2 141-143.
28. Heald A, Whitehead S, Anderson S, Cruickshank K, Riste L, Laing I, Rudenski A & Buckler H. Screening for insulin resistance in women with polycystic ovarian syndrome. Gynecological Endocrinology 2005 20 84-91.
29. Diamanti-Kandarakis E, Kouli C, Alexandraki K & Spina G. Failure of mathematical indices to accurately assess insulin resistance in lean, overweight, or obese Women with Polycystic Ovary Syndrome. Journal of Clinical Endocrinology and Metabolism 2004 89 1273-1276.